Johnson & Johnson
At DTx in Boston representatives of major pharma companies discussed opportunies of working with digital theraputics companies and what they wish the startups knew.
VitalConnect and physIQ are teaming up with the Haga Teaching Hospital in the Netherlands to conduct a study on how wearable biosensors and artificial intelligence can augment care for cancer patients undergoing treatment.
As Johnson & Johnson continues to move out of the diabetes business, the company has sold its Calibra product (marketed as OneTouch Via, but never launched) to CeQur, a 10-year-old company working on a similar insulin-delivery wearable.
Like almost any field in the healthcare industry pharma wants to get in on the latest technology trends.
Platinum Equity, a Los Angeles-based global investment firm focused on mergers, acquisitions, and operations, has made a binding offer to acquire Johnson & Johnsons' Chesterbrook, Pennsylvania and Zug, Switzerland-based LifeScan business, which sells the OneTouch line of connected and non-connected glucometers.
The US Food and Drug Administration has given the green light for a non-prescription version of BlueStar, WellDoc’s mobile diabetes management platform.
In addition to the many device launches, several digital health companies use CES (formerly known as the Consumer Electronic Show) in Las Vegas as an opportunity to announce updates and major partnerships and collaborations.
Boston-based Rest Devices has announced a collaboration with Johnson & Johnson to develop a smart, personalized sleep coaching system for babies (and their parents, hovering over their crib with a smartphone).
Johnson & Johnson has teamed up with Walgreens to integrate the Johnson & Johnson Official 7 Minute Workout app into the Walgreens Balance Rewards for healthy choices program.
McNeil Consumer Healthcare, the Johnson & Johnson subsidiary that makes over the counter medications like Tylenol and Zyrtec, has released a new mobile app, called Healthyday, that uses crowdsourced data to inform users about location-based allergy, cold, and flu trends.